NPI: 1609891225 · BALTIMORE, MD 21215 · General Acute Care Hospital · NPI assigned 07/13/2006
Authorized official EFIRD, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | EFIRD, CHARLES (DIRECTOR) |
| Parent Organization | SINAI HOSPITAL OF BALTIMORE INC |
| NPI Enumeration Date | 07/13/2006 |
Other providers sharing the same authorized official: EFIRD, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,449 | $100K |
| 2019 | 1,782 | $78K |
| 2020 | 1,468 | $47K |
| 2021 | 2,279 | $102K |
| 2022 | 3,290 | $124K |
| 2023 | 3,282 | $141K |
| 2024 | 2,082 | $81K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4,191 | 3,947 | $287K |
| 99215 | Prolong outpt/office vis | 2,614 | 2,462 | $203K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,625 | 1,511 | $72K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 586 | 220 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 267 | 262 | $21K |
| 99443 | 468 | 436 | $12K | |
| 99253 | 94 | 82 | $10K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 45 | 43 | $7K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 205 | 205 | $6K |
| 82962 | 4,203 | 3,938 | $6K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 31 | 30 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 925 | 870 | $4K |
| 99442 | 207 | 182 | $3K | |
| 99205 | Prolong outpt/office vis | 12 | 12 | $3K |
| 99223 | Prolong inpt eval add15 m | 16 | 13 | $2K |
| 99254 | 14 | 13 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 65 | 47 | $980.34 |
| 95251 | 25 | 25 | $775.51 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15 | 13 | $551.84 |
| J0897 | Injection, denosumab, 1 mg | 24 | 24 | $290.86 |